Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06526884

Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
1,080 (estimated)
Sponsor
University of California, Los Angeles · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The Next Day Clinic (NDC) is a quality improvement initiative that will be launched and operated by UCLA Health starting July 22, 2024. Its goals are to improve patient care and safety and to maximize cost effectiveness. The way it does this is by identifying patients in the ED who would normally be admitted for low-acuity conditions, and diverting them to a high-acuity clinic the following day called the NDC. This will help decompress the ED and the hospital, and allow for overall higher quality care. The Health System has partnered with UCLA's Healthcare Value Analytics and Solutions \[UVAS\] group which specializes in these types of program evaluations. The analysis conducted by the study team will be used to directly inform NDC operations, scaling, and future plans.

Detailed description

NDC is a hospital avoidance model with the potential to simultaneously improve the quality and safety of acute care, reduce costs, and address hospital/ED overcrowding. This novel hospital avoidance program will divert patients from the ED who have been diagnosed with the following conditions and meet certain clinical criteria: * Diabetic Foot Infection/Osteomyelitis * Cellulitis * Congestive Heart Failure * Syncope * Pyelonephritis/Urinary Tract Infection * Pneumonia * Acute Kidney Infection

Conditions

Interventions

TypeNameDescription
OTHERNext Day ClinicA dedicated Next Day Clinic team consisting of a clinician and nurse case manager will provide care and specialist referrals to patients within 24 hours of an ED visit that would have resulted in hospitalization without this novel hospital avoidance initiative.

Timeline

Start date
2024-07-22
Primary completion
2026-01-20
Completion
2026-04-01
First posted
2024-07-30
Last updated
2026-03-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06526884. Inclusion in this directory is not an endorsement.